The updated guidance, which was largely driven by lower-than-anticipated sales of GLP-1 blockbusters Mounjaro and Zepbound, ...

INDIANAPOLIS, Sept. 9, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the appointment of Lucas Montarce as executive vice president and chief financial officer (CFO ...

Pharmaceutical giant Eli Lilly (NYSE: LLY ... board of directors approved a $15 billion stock buyback program. CFO Lucas Montarce said of the share buyback: As Lilly has entered into a period ...

Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street ...

Eli Lilly & Co.’s fourth-quarter revenue fell short of analysts’ estimates as its popular weight-loss and diabetes shots disappointed investors for the second consecutive quarter. Most Read from ...

INDIANAPOLIS, Dec. 9, 2024 /PRNewswire/ -- Today, the board of directors of Eli Lilly and Company ... and business development," said Lucas Montarce, Lilly executive vice president and chief ...

INDIANAPOLIS - Eli Lilly and Company (NYSE:LLY), a global pharmaceutical firm, announced today the appointment of Lucas Montarce as the new Executive Vice President and Chief... Eli Lilly and ...

(Reuters) -Eli Lilly's stock tumbled 8% on Tuesday after ... As supply normalizes, Lilly's Chief Financial Officer Lucas Montarce said wholesalers did not seek to build up their stocks of ...